ADARx Pharmaceuticals, Inc.
ADRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802369
In the last 90 days, ADARx Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of ADRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ADARx Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of ADARx Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on ADARx Pharmaceuticals, Inc., newest first.
No Schedule 13D or 13G filings on ADARx Pharmaceuticals, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ADARx Pharmaceuticals, Inc. shares.
No Form 144 notices for ADARx Pharmaceuticals, Inc. are on file.